1461097282-77b24f60-efa6-4ad3-b062-39f3ed6380a6

1. A method for the decarboxylation of an organic carboxylic acid. comprising:
a) reacting an organic carboxylic acid of the formula (I):
wherein R is (C15-C19)alkyl, and Z are individually H or an organic group, with pivalic anhydride to yield a reaction mixture comprising a mixed anhydride of the formula (II):
R1\u2014C(O)\u2014O\u2014C(O)\u2014CH(Z)\u2014CH(Y)R\u2003\u2003(II)
wherein R1 is t-butyl;
b) reacting the mixed anhydride with a catalytic amount of Pd(PPh3)4, provided by combining PdCl2 with excess PPh3 so that Pd(PPh3)4 is about 0.01-0.1 mol -% of (I), to yield, an intermediate (III) of the formula|
R1\u2014C(O)\u2014O-Pd(PPh3)2\u2014C(O)CH(Z)\u2014CH(Y)R\u2003\u2003(III)
c) decomposing intermediate (III) to yield a compound of formula R\u2014C(Y)\u2550CH(Z) (IV) and P(Ph3)4, wherein steps (a)-(c) are carried out in the absence of a solvent; and
d) isolating the compound of formula (IV) from the reaction mixture by distillation at above about 190\xb0 C. at less than 1 atm pressure.
2. The method of claim 1 that is carried out at a temperature above about 200\xb0 C.
3. The method of claim that is carried out at about 195-250\xb0 C.
4. The method of claims wherein the distillation is carried out at about 10-30 Torr.
5. The method of claims 1, 2, 3 or 4 wherein Z and Y are H.
6. The method of claim 1, 2, 3, 4 or 5 wherein the compound of formula (I) is present in a vegetable or animal oil or fat.
7-21. (canceled)

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method for sharpening a silicon-based field emitter tip, the method comprising:
enclosing the silicon-based field emitter tip within a process chamber;
producing a room-temperature gas that reacts with silicon with high specificity and that produces a conformal isotropic etch profile; and
introducing the room-temperature gas into the process chamber to isotropically etch the rough field emitter tip to sharpness.
2. The method of claim 1 wherein the room-temperature gas is xenon difluoride.
3. A method for fabricating a sharp, silicon-based field emitter tip, the method comprising:
microfabricating a silicon well, surrounded laterally by a dielectric layer, above an underlying first metal layer with a second metal layer overlying the dielectric layer leaving a surface area of the silicon well exposed;
isotropically etching silicon within the silicon well to create a rough field emitter tip above the first metal layer; and
isotropically etching the rough field emitter tip with a room-temperature gas to produce the final, sharp silicon-based field emitter tip.
4. The method of claim 3 wherein isotropically etching silicon within the silicon well to create a rough field emitter tip above the first metal layer further comprises:
applying a photoresist layer to surface of the second metal layer;
photolithographically patterning a photoresist mask on the exposed surface of the silicon well, roughly centered within the exposed surface of the silicon well, with a surface area less than the surface area of the silicon well;
isotropically etching silicon within the silicon well to create a rough field emitter tip above the first metal layer and below the photoresist mask; and
removing the photoresist mask following isotropically etching silicon within the silicon well.
5. The method of claim 3 wherein isotropically etching silicon within the silicon well to create a rough field emitter tip above the first metal layer and below the photoresist mask further includes exposing the photoresist-masked silicon well to a plasma etch medium.
6. The method of claim 3 wherein the plasma etch medium employs a gas or gas mixture selected from various gas or gas mixtures that include:
Cl2;
BCl3;
SiCl4Cl2;
BCl3Cl2;
HBrCl2O2;
HBrO2;
Br2SF6;
SF6;
CF4;
CF3Br;
and HBrNF3.
7. The method of claim 3 wherein the photoresist mask is removed following isotropically etching silicon within the silicon well by plasma O2 stripping.
8. The method of claim 3 wherein the photoresist mask is removed following isotropically etching silicon within the silicon well by exposing the photoresist mask to a stripping solution selected from among stripping solutions including:
a solvent-based stripping solution;
a sulfonic acid and chlorinated hydrocarbon solvent stripping solution; and
a chromic acid and sulfuric acid stripping solution.
9. The method of claim 3 applied to array of silicon-based field emitter tips to produce an array of sharp, silicon-based field emitter tips.
10. The method of claim 3 wherein the room-temperature gas is xenon difluoride.
11. A method for preparing an array of sharp, silicon-based field emitter tips for use as a component in an electronic device, the method comprising:
microfabricating an array of silicon wells, each well surrounded laterally by a dielectric layer, above an underlying first metal layer with a second metal layer overlying the dielectric layer leaving a surface area of the silicon well exposed;
isotropically etching silicon within the silicon wells to create an array of rough field emitter tips above the first metal layer;
isotropically etching the rough field emitter tips with a room-temperature gas to produce an array of sharp, silicon-based field emitter tips; and
including the array of sharp, silicon-based field emitter tips in the electronic device.
12. The method of claim 10 wherein the room-temperature gas is xenon difluoride.
13. The method of claim 10 wherein the electronic device is a field emission display device.
14. The method of claim 10 wherein the electronic device is an ultra-high-density electronic memory device.

1461097272-7840b5d0-3f59-420b-8fa7-70325d2dd88b

1. A surgical kit comprising an insertion tool and an implant for addressing incontinence and cystocele disorders, the implant comprising:
a cystocele repair portion adapted to be secured in the patient’s vaginal region, comprising a major portion that is sized and shaped to afford repair of a cystocele without lifting the patient’s bladder and without placing tension on the bladder, the major portion including a urethral support portion capable of being placed underneath the patient’s urethra;
a first posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region toward a first incision in the patient’s buttocks that is lateral to the patient’s anus;
a second posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region, on a side of the patient’s anus different than that of the first posterior securement appendage, toward a second incision in the patient’s buttocks that is on a side of the patient’s anus opposite the first incision;
a first sling appendage for securement on a first side of the patient’s urethra; and
a second sling appendage for securement on a side of the patient’s urethra generally opposite the first side of the urethra;
wherein one or more of the first posterior securement appendage, the second posterior securement appendage, the first sling appendage, and the second sling appendage, includes a connector configured to engage a distal end of an insertion needle;

the insertion tool comprising a proximal end and a distal end, a handle at the proximal end, and the distal end being configured to engage the connector; and
wherein the mesh material comprises bulk knitted polypropylene monofilaments, and bulk material from which the mesh is supplied has at least a Longitudinal Elongation Factor (LEF) of 0.06 under a \xbd pound load.
2. A surgical kit comprising an insertion tool and an implant for addressing incontinence and cystocele disorders, the implant comprising:
a cystocele repair portion adapted to be secured in the patient’s vaginal region,
a first posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region toward a first incision in the patient’s buttocks that is lateral to the patient’s anus;
a second posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region, on a side of the patient’s anus different than that of the first posterior securement appendage, toward a second incision in the patient’s buttocks that is on a side of the patient’s anus opposite the first incision;
the implant including a urethral support portion capable of being placed underneath the patient’s urethra;
a first sling appendage for securement on a first side of the patient’s urethra; and
a second sling appendage for securement on a side of the patient’s urethra generally opposite the first side of the urethra;
wherein one or more of the first posterior securement appendage, the second posterior securement appendage, the first sling appendage, and the second sling appendage, includes a connector configured to engage a distal end of an insertion needle;

the insertion tool comprising a proximal end and a distal end, a handle at the proximal end, and the distal end being configured to engage the connector; and
wherein bulk material from which the mesh is supplied has at least a Longitudinal Elongation Factor (LEF) of more than about 0.08 under a \xbd pound load.
3. A surgical implant according to claim 2 wherein bulk material from which the mesh is supplied has at least a Longitudinal Elongation Factor (LEF) of more than about 0.15 under a \xbd pound load.
4. A surgical kit comprising an insertion tool and an implant for addressing incontinence and cystocele disorders, the implant comprising:
a cystocele repair portion adapted to be secured in the patient’s vaginal region;
a first posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region toward a first incision in the patient’s buttocks that is lateral to the patient’s anus;
a second posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region, on a side of the patient’s anus different than that of the first posterior securement appendage, toward a second incision in the patient’s buttocks that is on a side of the patient’s anus opposite the first incision;
the implant including a urethral support portion capable of being placed underneath the patient’s urethra;
a first sling appendage for securement on a first side of the patient’s urethra; and
a second sling appendage for securement on a side of the patient’s urethra generally opposite the first side of the urethra;
wherein one or more of the first posterior securement appendage, the second posterior securement appendage, the first sling appendage, and the second sling appendage, includes a connector configured to engage a distal end of an insertion needle;
the insertion tool comprising a proximal end and a distal end, a handle at the proximal end, and the distal end being configured to engage the connector;
bulk material from which the mesh is supplied has at least a Longitudinal Elongation Factor (LEF) of at least 0.06 under a \xbd pound load; and
bulk material from which the mesh is supplied has a Longitudinal Elongation Factor (LEF) of more than about 0.08 under a 1 pound load.
5. A surgical implant according to claim 4 wherein bulk material from which the mesh is supplied has a Longitudinal Elongation Factor (LEF) of more than about 0.1 under a 1 pound load.
6. A surgical implant according to claim 5 wherein bulk material from which the mesh is supplied has a Longitudinal Elongation Factor (LEF) of more than about 0.2 under a 1 pound load.
7. A surgical kit comprising an insertion tool and an implant for addressing incontinence and cystocele disorders, the implant comprising:
a cystocele repair portion adapted to be secured in the patient’s vaginal region;
a first posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region toward a first incision in the patient’s buttocks that is lateral to the patient’s anus;
a second posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region, on a side of the patient’s anus different than that of the first posterior securement appendage, toward a second incision in the patient’s buttocks that is on a side of the patient’s anus opposite the first incision;
the implant including a urethral support portion capable of being placed underneath the patient’s urethra;
a first sling appendage for securement on a first side of the patient’s urethra; and
a second sling appendage for securement on a side of the patient’s urethra generally opposite the first side of the urethra;
wherein one or more of the first posterior securement appendage, the second posterior securement appendage, the first sling appendage, and the second sling appendage, includes a connector configured to engage a distal end of an insertion needle;

the insertion tool comprising a proximal end and a distal end, a handle at the proximal end, the distal end being configured to engage the connector; and
wherein the connector is a dilating connector.
8. A surgical kit comprising an insertion tool and an assembly for addressing a female patient’s pelvic health disorder, the assembly comprising:
a portion adapted to be secured in the patient’s vaginal region;
a first posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region toward a first incision in the patient’s buttocks that is lateral to the patient’s anus;
a second posterior securement appendage that is sized, shaped and configured to extend from the patient’s vaginal region, on a side of the patient’s anus different than that of the first posterior securement appendage, toward a second incision in the patient’s buttocks that is on a side of the patient’s anus opposite the first incision;
the first and second posterior securement appendages including a connector for associating the first and second posterior securement appendages with a distal end of an insertion needle; and
the insertion tool comprising a handle and a needle, the needle comprising a proximal end extending from the handle and a distal end configured to engage a connector;
wherein the connector is a dilating connector.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A computer-implemented method for communicating data between a continuous glucose monitor and a handheld diabetes manager, comprising:
constructing, by a continuous glucose monitor, a data packet for transmission during a current time interval in a series of sequential time intervals, where the data packet includes blood glucose measures taken by the continuous glucose monitor during the current time interval;
resetting, by the continuous glucose monitor, a counter upon receiving an acknowledgement of receipt of a data packet transmitted during the preceding time interval;
incrementing, by the continuous glucose monitor, the counter upon failing to receive an acknowledgement of receipt of a data packet transmitting during a time interval preceding the current time interval;
appending, by the continuous glucose monitor, blood glucose measures taken by the continuous glucose measure during the preceding time interval to the data packet when the counter is less than a threshold;
transmitting, by the continuous glucose monitor, the data packet at a first data rate via a wireless data link to the handheld diabetes manager when the counter is less than the threshold;
storing, by the continuous glucose monitor, blood glucose measures taken by the continuous glucose monitor during the current time interval and the preceding time interval in a non-volatile memory, when the counter is equal to or exceeds the threshold and upon failing to receive an acknowledgement of receipt of a data packet transmitting; and
subsequent to storing the blood glucose measures in the non-volatile memory, transmitting, by the continuous glucose monitor, the blood glucose measures stored in the non-volatile memory at a second data rate higher than the first data rate.
2. The method of claim 1 further comprises further comprises receiving, by the continuous glucose monitor, a request to send data from the handheld diabetes manager, and transmitting, by the continuous glucose monitor, the data packet in response to the request to send data.
3. The method of claim 1 further comprises periodically sending, by the continuous glucose monitor, a beacon to the handheld diabetes manager, where the beacon includes data pertaining to an operating state of the continuous glucose monitor; and receiving, by the continuous glucose monitor, a request to send data from the handheld diabetes manager in response to the beacon.
4. The method of claim 3 further comprises transitioning, by the continuous glucose monitor, to a data exchange state from a beacon state in response to the request to send data, where the continuous glucose monitor operates in the data exchange state to consume electrical power at a higher rate than in the beacon state.
5. The method of claim 4 further comprises:
initiating, by the continuous glucose monitor, a timer having a predefined duration in response to the transmission of a data packet during the preceding time interval; and
appending, by the continuous glucose monitor, blood glucose measures taken by the continuous glucose monitor during the preceding time interval, upon expiration of the timer without receipt of a request to enter a beacon state from the handheld diabetes manager.
6. The method of claim 1 further comprises transmitting the data packet in accordance with ANT+ communication protocol.
7. The method of claim 1 further comprises receiving, by the continuous glucose monitor, a request to enter a file sharing mode from the handheld diabetes manager, and initiating a file sharing mode in response to the request to enter a file sharing mode.
8. The method of claim 7 further comprises monitoring, by the handheld diabetes manager, data packets received from the continuous glucose monitor, and sending, by the handheld diabetes manager, the request to enter a file sharing mode when the data packets expected but not received from the continuous glucose monitor exceeds a limit.
9. The method of claim 7 further comprises transmitting the blood glucose measures in the non-volatile memory in accordance with ANT-FS protocol.
10. A computer-implemented method for communicating data between a continuous glucose monitor and a handheld diabetes manager, comprising:
receiving, by the continuous glucose monitor, a request to send data from the handheld diabetes manager;
constructing, by the continuous glucose monitor, a data packet in response to the request to send data, the data packet includes blood glucose measures taken by the continuous glucose monitor during a first time interval;
appending, by the continuous glucose monitor, blood glucose measures to the data packet upon failing to receive an acknowledgement of receipt from the handheld diabetes manager, the blood glucose measures taken by the continuous glucose measure during a time interval preceding the first time interval;
transmitting, by the continuous glucose monitor, the data packet via a wireless data link to the handheld diabetes manager in accordance with ANT communication protocol;
receiving, by the continuous glucose monitor, a request to enter a file sharing mode from the handheld diabetes manager, where the request to enter a file sharing mode is sent by the handheld diabetes manager when data packets expected but not received from the continuous glucose monitor exceeds a threshold; and
sending, by the continuous glucose monitor, blood glucose measures to the handheld diabetes manager in response to the request to enter a file sharing mode, the blood glucose measures sent in accordance with the ANT-FS protocol.
11. The method of claim 10 further comprises periodically sending, by the continuous glucose monitor, a beacon to the handheld diabetes manager, where the beacon includes data pertaining to an operating state of the continuous glucose monitor; and receiving, by the continuous glucose monitor, the request to send data in response to the beacon.
12. The method of claim 11 further comprises transitioning, by the continuous glucose monitor, to a data exchange state from a beacon state in response to the request to send data, where the continuous glucose monitor operates in the beacon state to consume electrical power at a lower rate than in the data exchange state.
13. The method of claim 11 further comprises transitioning, by the continuous glucose monitor, to the beacon state from the data exchange state in response to a request to enter a beacon state received from the handheld diabetes manager, where the request to enter a beacon state serves as the acknowledgement.
14. A computer-implemented method for communicating data between a continuous glucose monitor and a handheld diabetes manager, comprising:
transmitting, by the continuous glucose monitor, a first data packet via a wireless data link to the handheld data manager during a first time interval in a series of sequential time intervals, wherein the first data packet includes blood glucose measures taken by the continuous glucose monitor prior to the first time interval and is transmitted in accordance with the ANT communication protocol;
receiving, by the continuous glucose monitor, an acknowledgement regarding the transmission of the first data packet;
retransmitting, by the continuous glucose monitor, the first data packet via the wireless data link to the handheld diabetes manager during the first time interval when the acknowledgement indicates an unsuccessful transmission of the first data packet;
receiving, by the continuous glucose monitor, an acknowledgement regarding the retransmission of the first data packet; and
transmitting, by the continuous glucose monitor, a second data packet via the wireless data link during a second time interval in the series of time intervals, wherein the second data packet includes blood glucose measures taken by the continuous glucose monitor during the first time interval and further includes blood glucose measures taken by the continuous glucose measure prior to the first time interval only when the acknowledgement indicates an unsuccessful retransmission of the first data packet.
15. The method of claim 14 further comprises periodically sending, by the continuous glucose monitor, a beacon to the handheld diabetes manager, where the beacon includes data pertaining to an operating state of the continuous glucose monitor; and receiving, by the continuous glucose monitor, a request to send data from the handheld diabetes manager.
16. The method of claim 15 further comprises transitioning, by the continuous glucose monitor, to a data exchange state from a beacon state in response to the request to send data, where the continuous glucose monitor operates to consume electrical power at a lower rate in the beacon state than in the data exchange state.
17. The method of claim 15 further comprises transmitting, by the continuous glucose monitor, the first data packet in response to the request to send data.
18. The method of claim 15 further comprises transitioning, by the continuous glucose monitor, to the beacon state from the data exchange state in response to a request to enter a beacon state received from the handheld diabetes manager.
19. The method of claim 14 further comprises receiving, by the continuous glucose monitor, a request to enter a file sharing mode from the handheld diabetes manager, and initiating a file sharing mode in response to the request to enter a file sharing mode.
20. The method of claim 19 further comprises monitoring, by the handheld diabetes manager, data packets received from the continuous glucose monitor, and sending, by the handheld diabetes manager, the request to enter a file sharing mode when the data packets expected but not received from the continuous glucose monitor exceeds a threshold.
21. The method of claim 19 further comprises sending, by the continuous glucose monitor, blood glucose measures to the handheld diabetes manager in accordance with the ANT-FS protocol.